DrugPatentWatch Database Preview
Quagen Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?
QUAGEN has five approved drugs.
Summary for Quagen
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Quagen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quagen | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040673-002 | Mar 5, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Quagen | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040673-001 | Mar 5, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Quagen | ALBUTEROL SULFATE | albuterol sulfate | SYRUP;ORAL | 212197-001 | Sep 6, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Quagen | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040673-003 | Mar 5, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Quagen | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | SYRUP;ORAL | 212423-001 | May 22, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Quagen | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080154-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
